Skip Navigation


JAC Advance Access originally published online on May 30, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):310-314; doi:10.1093/jac/dkl223
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/2/310    most recent
dkl223v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Soler, P.
Right arrow Articles by Usera, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soler, P.
Right arrow Articles by Usera, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001–2003

Pilar Soler1,*, Rubén González-Sanz2, María J. Bleda1, Gloria Hernández1, Aurora Echeíta2 and Miguel A. Usera3

1 Centro Nacional de Epidemiología, Instituto de Salud Carlos III Sinesio Delgado, 6, Madrid 28029, Spain 2 Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera de Majadahonda a Pozuelo, s/n 28220 Majadahonda, Madrid, Spain 3 Agencia Española del Medicamento, Ministerio de Sanidad y Consumo, Carretera de Majadahonda a Pozuelo, s/n 28220 Majadahonda, Madrid, Spain

Received 5 December 2005; returned 14 February 2006; revised 28 March 2006; accepted 8 May 2006


*Corresponding author. Tel: +34-91-8222645; Fax: +34-91-3877815; E-mail: psoler{at}isciii.es

Objectives: To determine the current state of antimicrobial resistance among non-typhoidal Salmonella strains isolated from humans in Spain.

Methods: All strains of Salmonella from human sources received in the reference laboratory from 2001 to 2003 were serotyped and phage types were determined in the most common serovars. A systematic sampling procedure was carried out in order to obtain a random sample for susceptibility testing. The selected strains were tested for susceptibility to 12 different antimicrobial agents by a disc diffusion method using Mueller–Hinton agar. Results were scored as susceptible, moderately susceptible or resistant, according to CLSI criteria.

Results: From 2001 to 2003, 5777 strains of Salmonella were tested for susceptibility. Fifty per cent of strains of Salmonella Enteritidis were resistant to nalidixic acid. This was the most frequent resistance pattern of this serovar and it was characteristic of PT1, the most frequent phage type of Salmonella Enteritidis in Spain. Seventy-four per cent of Salmonella Typhimurium strains were resistant to four antibiotics or more. Resistance to ampicillin, chloramphenicol, streptomycin, sulphonamide and tetracycline was the most frequent resistance pattern of Salmonella Typhimurium and it was characteristic of DT104, the most frequent phage type in Spain. Sixty-nine per cent of Salmonella Hadar strains were resistant to at least four antibiotics.

Conclusions: The results of our study showed both a worrying percentage of strains of Salmonella Enteritidis resistant to nalidixic acid and of strains of Salmonella Typhimurium with a pattern of resistance to four antibiotics or more. Surveillance of antimicrobial resistance should carry on and improve in order to be able to evaluate the control measures carried out for decreasing resistance in Salmonella, specifically that addressed to the prudent use of antimicrobial agents by farmers and veterinarians.

Keywords: salmonellosis , zoonoses , drug-resistant


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Vet Rec.Home page
J. J. Carrique-Mas, C. Papadopoulou, S. J. Evans, A. Wales, C. J. Teale, and R. H. Davies
Trends in phage types and antimicrobial resistance of Salmonella enterica serovar Enteritidis isolated from animals in Great Britain from 1990 to 2005
Vet Rec., April 26, 2008; 162(17): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
U. N. Ikumapayi, M. Antonio, J. Sonne-Hansen, E. Biney, G. Enwere, B. Okoko, C. Oluwalana, A. Vaughan, S. M. A. Zaman, B. M. Greenwood, et al.
Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri
J. Med. Microbiol., November 1, 2007; 56(11): 1479 - 1484.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.